ID: ALA4294494

Max Phase: Preclinical

Molecular Formula: C12H19N3O2S

Molecular Weight: 269.37

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)NC1=NN(C(C)=O)C2(CCCCCC2)S1

Standard InChI:  InChI=1S/C12H19N3O2S/c1-9(16)13-11-14-15(10(2)17)12(18-11)7-5-3-4-6-8-12/h3-8H2,1-2H3,(H,13,14,16)

Standard InChI Key:  TXFVZMJOJPIMRY-UHFFFAOYSA-N

Associated Targets(Human)

Kinesin-like protein 1 1720 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 269.37Molecular Weight (Monoisotopic): 269.1198AlogP: 2.04#Rotatable Bonds: 0
Polar Surface Area: 61.77Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.69CX Basic pKa: CX LogP: 1.78CX LogD: 1.78
Aromatic Rings: 0Heavy Atoms: 18QED Weighted: 0.73Np Likeness Score: -0.84

References

1. Talapatra SK, Tham CL, Guglielmi P, Cirilli R, Chandrasekaran B, Karpoormath R, Carradori S, Kozielski F..  (2018)  Crystal structure of the Eg5 - K858 complex and implications for structure-based design of thiadiazole-containing inhibitors.,  156  [PMID:30031975] [10.1016/j.ejmech.2018.07.006]

Source